Histone Modifying Enzymes as Targets for Therapeutic Intervention in Oesophageal Adenocarcinoma

SIMPLE SUMMARY: Despite advances in both the surgical and medical management of oesophageal adenocarcinoma (OAC), overall prognosis remains poor, with less than 1 in 5 patients surviving more than 5 years from diagnosis. Patients suitable for treatment with curative intent receive pre-operative chem...

Descripción completa

Detalles Bibliográficos
Autores principales: Pickering, Oliver J., Breininger, Stella P., Underwood, Timothy J., Walters, Zoë S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392153/
https://www.ncbi.nlm.nih.gov/pubmed/34439236
http://dx.doi.org/10.3390/cancers13164084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392153/
https://www.ncbi.nlm.nih.gov/pubmed/34439236
http://dx.doi.org/10.3390/cancers13164084

Ejemplares similares